| Biogen INC BIOGEN INC ORD SHS | 257.70 / +0.11% |
| Date/Time | 10/27 / 17:44 |
| Chg. / Chg.(%) | 0.28 / +0.11% |
| Bid | - |
| Ask | - |
| Open | 257.38 |
| Previous Close | 257.42 |
| High | 257.70 |
| Low | 256.74 |
| Volume [USD] | 8,226.34 |
| Volume [Units] | 32 |
| Price fixings | 7 |
| ISIN | US09062X1037 |
| Security | 0R1B |
| Exchange | London International |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 257.5900 |  |
563,145 |
| IEX | 257.19 | |
49,904 |
| Cboe US | 257.48 | |
27,613 |
| TradeGate | 218.000 | |
644 |
| Xetra | 217.80 | |
87 |
| Frankfurt | 217.0500 |  |
76 |
| Stuttgart | 217.150 | |
58 |
| Vienna Globa.. | 217.90 | |
42 |
| London Inter.. | 257.70 | |
32 |
| gettex | 217.450 | |
13 |
| München | 216.75 | |
0 |
| Hamburg | 216.30 | |
0 |
| Düsseldorf | 217.15 | |
0 |
| Berlin | 217.30 | |
0 |
| Hannover | 216.30 | |
0 |
| Lang & Schwa.. | 217.600 | |
|
| SIX Swiss Ex.. | 232.00 | ||
| Mexico | 5,815.00 | |
54 |
News
- Biogen's Q3 revenue down 6% YoY to $3.38B
10/21/2020 / 13:04 - TeleTrader - Samsung Bioepis and Biogen Announce EMA Filing Acceptance of SB11, a Proposed Biosimilar Referencing Lucentis® (ranibizumab)
10/06/2020 / 13:00 - GlobeNewswire - Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public Health
09/14/2020 / 13:30 - GlobeNewswire - New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of Biogen’s Industry-Leading MS Portfolio
09/11/2020 / 14:01 - GlobeNewswire - New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS
09/08/2020 / 13:30 - GlobeNewswire
Real-time